CN1202866C - Gastrointestinal contrast agent containing biomass - Google Patents
Gastrointestinal contrast agent containing biomass Download PDFInfo
- Publication number
- CN1202866C CN1202866C CN 03112182 CN03112182A CN1202866C CN 1202866 C CN1202866 C CN 1202866C CN 03112182 CN03112182 CN 03112182 CN 03112182 A CN03112182 A CN 03112182A CN 1202866 C CN1202866 C CN 1202866C
- Authority
- CN
- China
- Prior art keywords
- biomass
- water
- medical
- contrast agent
- gastrointestinal contrast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002028 Biomass Substances 0.000 title claims abstract description 29
- 239000002872 contrast media Substances 0.000 title claims abstract description 23
- 230000002496 gastric effect Effects 0.000 title claims abstract description 23
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims abstract description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000000463 material Substances 0.000 claims abstract description 26
- 238000010521 absorption reaction Methods 0.000 claims abstract description 17
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 229920002545 silicone oil Polymers 0.000 claims abstract description 5
- 235000011194 food seasoning agent Nutrition 0.000 claims abstract description 4
- 239000000047 product Substances 0.000 claims description 17
- 235000010489 acacia gum Nutrition 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 235000013305 food Nutrition 0.000 claims description 11
- 229940023462 paste product Drugs 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 5
- 239000003292 glue Substances 0.000 claims description 5
- 229920002488 Hemicellulose Polymers 0.000 claims description 4
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 229920002101 Chitin Polymers 0.000 claims description 3
- 229920001615 Tragacanth Polymers 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 239000012043 crude product Substances 0.000 claims description 3
- 239000013530 defoamer Substances 0.000 claims description 3
- 239000002002 slurry Substances 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 2
- 239000003651 drinking water Substances 0.000 claims description 2
- 235000020188 drinking water Nutrition 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 241000416162 Astragalus gummifer Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- JMEAEHNDNWURDB-UHFFFAOYSA-N [K].[Os].C(CC(O)(C(=O)O)CC(=O)O)(=O)O Chemical compound [K].[Os].C(CC(O)(C(=O)O)CC(=O)O)(=O)O JMEAEHNDNWURDB-UHFFFAOYSA-N 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 claims 1
- 230000002421 anti-septic effect Effects 0.000 claims 1
- 239000004568 cement Substances 0.000 claims 1
- 235000015110 jellies Nutrition 0.000 claims 1
- 239000008274 jelly Substances 0.000 claims 1
- 235000010487 tragacanth Nutrition 0.000 claims 1
- 239000000196 tragacanth Substances 0.000 claims 1
- 229940116362 tragacanth Drugs 0.000 claims 1
- 239000000843 powder Substances 0.000 abstract description 54
- 238000003384 imaging method Methods 0.000 abstract description 8
- 229910052751 metal Inorganic materials 0.000 abstract description 8
- 239000002184 metal Substances 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 231100000252 nontoxic Toxicity 0.000 abstract description 6
- 230000003000 nontoxic effect Effects 0.000 abstract description 6
- 238000002156 mixing Methods 0.000 abstract description 4
- 239000012752 auxiliary agent Substances 0.000 abstract description 3
- -1 barium sulfate Chemical class 0.000 abstract description 3
- 230000005176 gastrointestinal motility Effects 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 229910052788 barium Inorganic materials 0.000 description 13
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 13
- 235000013399 edible fruits Nutrition 0.000 description 11
- 244000215068 Acacia senegal Species 0.000 description 10
- 229920000084 Gum arabic Polymers 0.000 description 10
- 239000000205 acacia gum Substances 0.000 description 10
- 244000017020 Ipomoea batatas Species 0.000 description 9
- 235000002678 Ipomoea batatas Nutrition 0.000 description 9
- 229920002472 Starch Polymers 0.000 description 8
- 210000001035 gastrointestinal tract Anatomy 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000008107 starch Substances 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 235000013339 cereals Nutrition 0.000 description 6
- 241000792859 Enema Species 0.000 description 5
- 239000007920 enema Substances 0.000 description 5
- 229940095399 enema Drugs 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- 239000004302 potassium sorbate Substances 0.000 description 4
- 229940069338 potassium sorbate Drugs 0.000 description 4
- 235000010241 potassium sorbate Nutrition 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 235000015067 sauces Nutrition 0.000 description 4
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 3
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 3
- 235000009685 Crataegus X maligna Nutrition 0.000 description 3
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 3
- 235000009486 Crataegus bullatus Nutrition 0.000 description 3
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 3
- 235000009682 Crataegus limnophila Nutrition 0.000 description 3
- 240000000171 Crataegus monogyna Species 0.000 description 3
- 235000004423 Crataegus monogyna Nutrition 0.000 description 3
- 235000002313 Crataegus paludosa Nutrition 0.000 description 3
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 3
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 3
- 229920000715 Mucilage Polymers 0.000 description 3
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 235000002949 phytic acid Nutrition 0.000 description 3
- 229940068041 phytic acid Drugs 0.000 description 3
- 239000000467 phytic acid Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 244000144730 Amygdalus persica Species 0.000 description 2
- 241001313857 Bletilla striata Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 235000005072 Vigna sesquipedalis Nutrition 0.000 description 2
- 244000090207 Vigna sesquipedalis Species 0.000 description 2
- 239000000305 astragalus gummifer gum Substances 0.000 description 2
- MJBPUQUGJNAPAZ-AWEZNQCLSA-N butin Chemical compound C1([C@@H]2CC(=O)C3=CC=C(C=C3O2)O)=CC=C(O)C(O)=C1 MJBPUQUGJNAPAZ-AWEZNQCLSA-N 0.000 description 2
- 229940109275 cyclamate Drugs 0.000 description 2
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 235000021278 navy bean Nutrition 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 241001474374 Blennius Species 0.000 description 1
- MJBPUQUGJNAPAZ-UHFFFAOYSA-N Butine Natural products O1C2=CC(O)=CC=C2C(=O)CC1C1=CC=C(O)C(O)=C1 MJBPUQUGJNAPAZ-UHFFFAOYSA-N 0.000 description 1
- 244000025596 Cassia laevigata Species 0.000 description 1
- 235000006693 Cassia laevigata Nutrition 0.000 description 1
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000007905 drug manufacturing Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960004503 metoclopramide Drugs 0.000 description 1
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000000025 natural resin Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 229960005382 phenolphthalein Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
含生物质的胃肠造影剂,属于医用x线胃肠造影剂技术领域。其特点是在传统的以无毒害金属盐类(如硫酸钡等)高吸收X-Ray材料[A]为主要材料的造影剂中加入超细粉末的生物质来源的低吸收X-Ray材料[B](或)以及粘结、调和、调味等辅助剂[C]、硅油等消泡剂[D]和水[E]组成,[A]+[B]+[C]+[D]+[E]=0.5~99.5%+0.5~99.5%+0~5%+0~1%+0~99%=100%(w/w)。既能良好地造影,又能强化造影效果,促进胃肠蠕动,是“绿色”概念的新型胃肠造影剂。A gastrointestinal contrast agent containing biomass belongs to the technical field of medical X-ray gastrointestinal contrast agents. It is characterized by adding ultra-fine powder low-absorption X-Ray material from biomass to traditional non-toxic metal salts (such as barium sulfate, etc.) high-absorption X-Ray material [A] as the main material [A] B] (or) and auxiliary agents such as bonding, blending and seasoning [C], silicone oil and other defoamers [D] and water [E], [A]+[B]+[C]+[D]+ [E] = 0.5-99.5% + 0.5-99.5% + 0-5% + 0-1% + 0-99% = 100% (w/w). It can not only perform good imaging, but also enhance the contrast effect and promote gastrointestinal motility. It is a new type of gastrointestinal contrast agent with the concept of "green".
Description
(一)技术领域:(1) Technical field:
本发明涉及一种含生物质的胃肠造影剂,主要用于医用口服X-Ray胃肠造影,属于医用药物制造领域。The invention relates to a gastrointestinal contrast agent containing biomass, which is mainly used for medical oral X-Ray gastrointestinal contrast agent and belongs to the field of medical drug manufacturing.
(二)背景技术:(two) background technology:
以往的X-Ray胃肠造影剂主要是使用硫酸钡等在胃肠道内无毒害的金属盐类高吸收X-Ray的材料细粉末为材料,辅之以香味剂等调味的粉状剂,调成浆状喝下或灌肠使用。典型的如钡餐:“医用硫酸钡100~120g加水200ml和阿拉伯胶适量也可用桃胶浆、医用可溶性羧甲基纤维素、西黄芪胶、白芨胶等代替。”(《医疗护理技术操作规范》,楼方岑等,中国人民解放军战士出版社,北京,1982.P.1568)。In the past, X-Ray gastrointestinal contrast agent mainly used non-toxic metal salts such as barium sulfate in the gastrointestinal tract and high-absorption X-Ray material fine powder as the material, supplemented by flavoring powders such as flavoring agents to adjust Slurry to drink or use as an enema. A typical barium meal: "100-120g of medical barium sulfate, 200ml of water and appropriate amount of gum arabic can also be replaced by peach mucilage, medical soluble carboxymethyl cellulose, tragacanth gum, bletilla striata gum, etc." ("Medical Nursing Technical Operation Specification" , Lou Fangcen, etc., Chinese People's Liberation Army Soldiers Publishing House, Beijing, 1982.P.1568).
传统的钡餐行之有效,但也有一些问题是硫酸钡(等无毒害的金属盐类高吸收X-Ray材料)细粉末浓度较高、比重较大易形成沉淀、悬浮不好或胶质物粘滞食用不便或口感不好;进入消化道后不能有效促进胃肠蠕动,因而下行不畅,特别是与实际食物存在状态时胃肠功能作用和条件相去较远,全消化道造影时矛盾比较突出;而且“胃肠造影后有时可引起便秘”(《临床药物手册》龙熴等,金盾出版社,北京,1993.P.957);由于“浓度”相对较高,悬浮稳定性必然较差,易于沉淀,虽然可以靠挤压观察有关区域,但有时还是会影响成像;由于以往的钡餐在下行过程中其水分逐渐地被吸收,到肠道下段时,仅仅剩下钡餐的硫酸钡粉末成分为主,而容易成为较硬结的粉末块团,体积和分布性、涂布性已较差,对肠道的造影效果并不理想,这是最大的问题之一,为了对肠道观察细致,就不得不依靠从下部再来个钡灌肠确认不可,事倍功半;另外,较高含量的硫酸钡粉末X-Ray阻档率高,成像反差大,虽然有利一面是定性准确、效果较好,但其上述的负面作用也同时增加,另一面就是在运行和成像过程中如此高的浓度不是必要和必须,在肠下段时其浓度的增加和体积的缩小,延展性、涂布性进一步降低,已影响到造影效率,也不能奢求形成层次感。成像、造影效果并不是很好了。The traditional barium meal is effective, but there are some problems that the fine powder of barium sulfate (such as non-toxic metal salts with high absorption X-Ray materials) has a high concentration and a large specific gravity, which is easy to form precipitates, poor suspension or sticky colloids. It is inconvenient to eat or the taste is not good; after entering the digestive tract, it cannot effectively promote gastrointestinal peristalsis, so the descending is not smooth, especially when it is far from the gastrointestinal function and conditions when the actual food exists, and the contradiction is more prominent when the whole digestive tract is contrasted ; and "sometimes constipation may be caused after gastrointestinal contrast" ("Clinical Drug Handbook" Long Xie et al., Jindun Publishing House, Beijing, 1993.P.957); because the "concentration" is relatively high, the suspension stability must be poor, It is easy to precipitate, although the relevant area can be observed by squeezing, but sometimes it will affect the imaging; because the water in the previous barium meal is gradually absorbed during the downward process, when it reaches the lower intestinal tract, only the barium sulfate powder of the barium meal is left. Mainly, it is easy to become hardened powder agglomerates, the volume, distribution, and spreadability are poor, and the contrast effect on the intestinal tract is not ideal. This is one of the biggest problems. In order to observe the intestinal tract carefully, it is necessary to We have to rely on a barium enema from the lower part to confirm that it is not possible, and the result is twice the result with half the effort; in addition, the higher content of barium sulfate powder has a high X-Ray blocking rate and a large imaging contrast. The negative effect also increases at the same time. On the other hand, such a high concentration is not necessary and necessary during the operation and imaging process. The increase in concentration and the reduction in volume in the lower intestinal segment will further reduce the ductility and spreadability, which has affected the contrast. Efficiency, nor can we expect to form a sense of hierarchy. The imaging and contrast effects are not very good.
(三)发明内容:(3) Contents of the invention:
本发明针对现有技术的不足,提供了一种医用新型口服X-Ray胃肠造影剂,具体讲是一种含生物质的胃肠造影剂。特征在于由适用于胃肠造影剂使用的、细度0.5~1.0微米的金属盐类高吸收X-Ray材料[A]和其细度在最大维度≤100微米的超细粉末的生物质来源的低吸收X-Ray材料[B]或以及粘结、调和、调味辅助剂[C]、消泡剂硅油[D]和水[E]组成,其中各组分的重量百分比如下:Aiming at the deficiencies of the prior art, the present invention provides a novel medical oral X-Ray gastrointestinal contrast agent, specifically a biomass-containing gastrointestinal contrast agent. It is characterized in that it is suitable for the use of gastrointestinal contrast agents, and the metal salt high-absorption X-Ray material [A] with a fineness of 0.5-1.0 microns and a biomass-sourced ultrafine powder whose fineness is ≤100 microns in the largest dimension Low-absorption X-Ray material [B] or as well as bonding, blending, flavoring aids [C], defoamer silicone oil [D] and water [E], wherein the weight percentage of each component is as follows:
[A]:0.5~99.5%[A]: 0.5 to 99.5%
[B]:0.5~99.5%[B]: 0.5 to 99.5%
[C]:0~5%[C]: 0 to 5%
[D]:0~1%[D]: 0~1%
[E]:0~99%。[E]: 0 to 99%.
本发明所述的由传统的适用于胃肠造影剂使用的金属盐类高吸收X-Ray材料[A]是指医用硫酸钡、枸橼酸锇(铋)钾、其他,及其复合、复配物。The traditional metal salt high-absorption X-Ray material [A] that is suitable for gastrointestinal contrast agents used in the present invention refers to medical barium sulfate, osmium citrate (bismuth) potassium, others, and their composites and complexes. compound.
显然,本发明是在传统的以无毒害金属盐类(如硫酸钡等)高吸收X-Ray材料[A]为主要材料的造影剂中加入“稀释剂”,所谓“稀释剂”主要是由超细粉末的生物来源的低吸收X-Ray材料[B]是指生物来源的、不可被消化吸收的纤维素、半纤维素、果胶质、几丁质类、或其它生物质类常温水不溶或难溶物质精品粗品或类似物(如谷物等表皮)、不可被消化吸收的超细粉末等单一或及其复合、复配组成;其细度在最大维度≤100微米,即其最大维度大小大致在人肉眼分辨率以下。该种“稀释剂”与传统的造影主要材料、以无毒害金属盐类(如硫酸钡等,规格可按一般传统使用的医学要求规范;必要时,采用粒度,有人提出颗粒要求是0.5~1.0微米为好。《临床医师诊疗全书》,王育才等,中国科学技术出版社,北京,1992.P.1002)高吸收X-Ray材料[A]复配时,在水分[E]和粘结、调和、调味等辅助剂[C]等共同作用下,粒度细度较小的无毒害金属盐类(如硫酸钡等)高吸收X-Ray材料[A]均匀、充分“包裹”在粒度、细度相仿一般是粒度、细度较大的生物质来源的低吸收X-Ray材料[B]的周围,既能良好地造影,又能充分“稀释”、“分散”造影剂,又不会影响造影效果和消化道内表面细微结构的成像表现,因为一般消化道内表结构均小于一般细胞(7~70微米),而且人肉眼的分辨率是在70~100微米,故而不会影响细微处的成像和造影,而且由于黏附作用,还会强化造影效果。Apparently, the present invention is to add " diluent " in the traditional contrast agent that is main material with nontoxic metal salts (as barium sulfate etc.) high absorption X-Ray material [A], so-called " diluent " is mainly made of Ultrafine powder bio-sourced low-absorption X-Ray material [B] refers to bio-sourced, non-digestible and absorbable cellulose, hemicellulose, pectin, chitin, or other biomass-based normal temperature water Insoluble or poorly soluble fine-quality crude products or analogs (such as grains and other epidermis), non-digestible ultra-fine powders, etc., or their composites and compound compositions; the fineness of which is ≤ 100 microns in the largest dimension, that is, the largest dimension The size is roughly below the resolution of the human eye. This kind of "diluent" and the main material of traditional radiography, with non-toxic metal salts (such as barium sulfate, etc., the specifications can be regulated according to the general traditional medical requirements; when necessary, the particle size is used, and some people propose that the particle size is 0.5 ~ 1.0 Micron is better. "Complete Book of Diagnosis and Treatment for Clinicians", Wang Yucai, etc., China Science and Technology Press, Beijing, 1992.P.1002) When the high-absorbing X-Ray material [A] is compounded, the moisture [E] and adhesion Under the joint action of auxiliary agents such as [C], blending, and seasoning, the non-toxic metal salts with small particle size (such as barium sulfate, etc.) and high-absorption X-Ray materials [A] are evenly and fully "wrapped" in the particle size, The surroundings of low-absorption X-Ray materials [B] derived from biomass with similar fineness and larger particle size can not only provide good imaging, but also fully "dilute" and "disperse" the contrast agent without Affects the contrast effect and the imaging performance of the fine structure of the inner surface of the digestive tract, because the inner surface structure of the general digestive tract is smaller than ordinary cells (7-70 microns), and the resolution of the human eye is 70-100 microns, so it will not affect the subtleties Imaging and contrast, and due to adhesion, the contrast effect will be enhanced.
本发明所述的生物质来源的低吸收X-Ray材料[B]是指生物质来源的医用、食用级的不可被消化吸收的纤维素、半纤维素、果胶质、几丁质类、或其它生物质类常温水不溶或难溶物质精品、粗品的,细度在最大维度≤100微米的超细粉末的单一或及其复合、复配物。Biomass-derived low-absorption X-Ray material [B] of the present invention refers to biomass-derived medical and food-grade non-digestible cellulose, hemicellulose, pectin, chitin, Or other biomass insoluble or difficult to dissolve in water at room temperature, high-quality products, crude products, ultrafine powders with a fineness of ≤100 microns in the largest dimension or their composites and complexes.
生物质来源的不可完全被消化吸收的低吸收X-Ray材料[B]的一些制法:Some preparation methods of low-absorption X-Ray materials [B] derived from biomass that cannot be completely digested and absorbed:
(一)、粉末(1), powder
1、全麸皮:清洗与否两种,磨细达标。1. Whole bran: There are two kinds of cleaning or not, and the grinding is up to the standard.
2、分解植酸全麸皮,酵母发酵,分解植酸,清洗与否两种,磨细。2. Decompose phytic acid whole bran, ferment with yeast, decompose phytic acid, wash or not, grind finely.
3、精制麸皮,保温酶解,去除部分或全部蛋白质、淀粉及植酸,磨细3. Refined bran, heat preservation and enzymatic hydrolysis, remove part or all of protein, starch and phytic acid, grind finely
4、豆皮4. Bean curd
5、甘薯粉末:甘薯去皮,蒸熟,切片,干制,粉碎,筛分获得小于80目的粉末。5. Sweet potato powder: sweet potato is peeled, steamed, sliced, dried, crushed, and sieved to obtain a powder of less than 80 mesh.
(二)、酱、浆液,含水量适宜即是。(2) For sauce and slurry, the water content should be appropriate.
1、甘薯去皮,蒸熟,打浆,胶体磨,筛分细度最大颗粒直径小于100微米。1. Sweet potatoes are peeled, steamed, beaten, colloid milled, and sieved with a maximum particle diameter of less than 100 microns.
2、山楂去皮、去核,蒸熟,打浆,胶体磨,筛分细度最大颗粒直径小于100微米。2. Hawthorn is peeled, pitted, steamed, beaten, colloid milled, and sieved with a maximum particle diameter of less than 100 microns.
本发明所述的生物质来源的不可完全被消化吸收的低吸收X-Ray材料[B]是常温水不溶或难溶物质是纯度较高的纤维素、半纤维素、果胶质、或几丁质等。但是为降低成本考虑,其粗品或类似物(如谷物等表皮)也可以采用。一般可以是来源于谷物等籽粒皮,如谷糠、豌豆及大豆皮等的细致加工粉末,也可以以某些细致加工的水果皮或水果以及块根、块茎等干燥粉末或其浆液完全或部分替代。所有加工,关键在于其粒度须符合本发明的要求。在许多情况下,为了充分达到和追求本发明所述的生物质来源的低吸收X-Ray材料[B]的常温水不溶或难溶性、不可消化性物质的相对含量,需要一些工艺去除一般谷物等籽粒皮,如谷糠、豌豆及大豆皮等中的可溶和可消化性物质。譬如一般的尚含有较多量的人体可消化吸收的蛋白质、淀粉等,所含纤维一般仅在25~35%左右,如欲提高其食用纤维类物质的相对含量,需要进行一些处理,譬如充分漂洗掉小米谷糠上的蛋白质、淀粉等物质;以及一般的酶法处理去除蛋白质、淀粉等物质,等使其食用纤维类物质增加,这种技术属于常规技术,也可以参考比照美国专利US4765994A和US4774096A中提及的食用纤维的类似制备方法。The low-absorption X-Ray material [B] that cannot be fully digested and absorbed by the biomass source described in the present invention is insoluble in normal temperature water or insoluble matter is cellulose, hemicellulose, pectin, or almost pure cellulose. Butin, etc. But for cost reduction consideration, its rough product or similar (such as epidermis such as grain) also can adopt. Generally, it can be finely processed powder derived from grain skins such as grains, such as bran, pea, and soybean skins, or it can be completely or partially replaced by some finely processed fruit skins or dry powders such as fruits, roots, tubers, etc. . All processing, the key is that its particle size must meet the requirement of the present invention. In many cases, in order to fully achieve and pursue the relative content of normal temperature water-insoluble or insoluble and non-digestible substances of the low-absorption X-Ray material [B] of biomass origin described in the present invention, some processes are required to remove general grains Soluble and digestible substances in grain skins, such as bran, pea and soybean skins. For example, ordinary ones still contain a large amount of protein, starch, etc. that can be digested and absorbed by the human body, and the fiber content is generally only about 25-35%. Remove protein, starch and other substances on millet bran; and general enzymatic treatment to remove protein, starch and other substances to increase dietary fiber substances. This technology is a conventional technology, and you can also refer to US patents US4765994A and US4774096A A similar preparation method to the dietary fiber mentioned in .
本发明所述的粘结、调和、调味辅助剂[C]是指医用、食用级的香味剂、甜味剂、酸味剂、防腐剂、以及医用、食用级的海藻胶、黄原胶、阿拉伯胶、桃胶浆等天然树脂胶、可溶性羧甲基纤维素、西黄芪胶、白芨胶天然生物质来源的高分子材料胶浆类,或其他非生物来源的医用、食用级的高分子材料分散粘结剂辅助成分。The bonding, blending and flavoring auxiliary agent [C] of the present invention refers to medical and food grade flavoring agents, sweeteners, sour agents, preservatives, and medical and food grade seaweed gum, xanthan gum, arabic Glue, peach glue and other natural resin glue, soluble carboxymethyl cellulose, tragacanth gum, bletilla striata gum natural biomass-derived polymer material mucilage, or other non-biological sources of medical and food-grade polymer material dispersion Binder auxiliary component.
本发明所述的硅油等消泡剂[D]是指医用、食用级硅油和其他医用、食用级表面活性剂组成。The defoamer [D] such as silicone oil in the present invention refers to the composition of medical and food grade silicone oil and other medical and food grade surfactants.
本发明所使用的水[E]是指医用、食用级的符合卫生指标的医用无菌水或饮用水。The water [E] used in the present invention refers to medical sterile water or drinking water of medical and food grades that meet the hygienic index.
本发明所提供的含生物质的胃肠造影剂也可以与传统钡餐剂、钡胶浆剂配合使用。即首先使用适量传统的硫酸钡高浓度、底稠度、涂布性良好的钡胶浆剂,对上消化道(主要是粘膜部分等)部分进行一定观察之后,而后使用既有传统钡剂特点,但含有较多固形物(生物质类物质的超细粉末等)浓度较低、具有较大体积的本发明所提供的含生物质的胃肠造影剂。一般来说,调整配方成分,本发明所提供的含生物质的胃肠造影剂均可以达到传统钡剂的所有效果,满足一切要求。The gastrointestinal contrast agent containing biomass provided by the present invention can also be used in conjunction with traditional barium meal and barium glue. That is, first use an appropriate amount of traditional barium sulfate high-concentration, low-consistency, and good-spreading barium mucilage, after observing the upper gastrointestinal tract (mainly the mucous membrane, etc.), and then use the characteristics of traditional barium, However, the biomass-containing gastrointestinal contrast agent provided by the present invention contains more solids (ultrafine powder of biomass substances, etc.) and has a lower concentration and a larger volume. Generally speaking, the gastrointestinal contrast agent containing biomass provided by the present invention can achieve all the effects of the traditional barium agent and meet all requirements by adjusting the formula components.
其他可按一般常规根据具体情况加入产气剂,胃复安,吗叮琳、番泻叶、果导(酚酞)、等。并注意调节(以生理盐水等物质)渗透压。Other gas-generating agents, metoclopramide, morphine, senna, phenolphthalein, etc. can be added according to the general routine and specific conditions. And pay attention to adjusting (with saline and other substances) osmotic pressure.
本发明所述的产品状态具有三种基本形式之一,所述三种基本形式分别是:①用水调和后使用的粉状品,②直接使用或食用或适当加水稀释使用的酱膏状品,③可供使用时直接食用的糊浆状品。The product state of the present invention has one of three basic forms, and the three basic forms are: ① a powder product mixed with water for use; ② a sauce paste product for direct use or eating or diluted with water; ③It is a pasty product that can be eaten directly when it is ready for use.
所有配方物质最终产品都应除菌、杀菌和无害化处理。杀菌方法使用加热、鈷60等辐射等等,可根据生产情况灵活选用。The final products of all formula substances should be sterilized, sterilized and harmless. The sterilization method uses heating, radiation such as cobalt 60, etc., which can be flexibly selected according to the production situation.
(四)具体实施方式:(4) Specific implementation methods:
下面几个实施例,均符合基本配方,在其范围内的配方优化。The following several embodiments all meet the basic formula, and the formula optimization within its scope.
实施例1.粉状品:在使用时医护人员根据情况和要求用水来调和。Embodiment 1. Powder product: when in use, the medical staff will mix it with water according to the situation and requirements.
硫酸钡20~70%、麸皮(或谷糠等,经去除蛋白质和淀粉的处理或否)细粉20~70%、阿拉伯胶粉0.5~1.5%、糖粉8~9%、酸味剂及香精适量。20-70% barium sulfate, 20-70% fine powder of bran (or rice bran, treated or not after removing protein and starch), 0.5-1.5% gum arabic powder, 8-9% sugar powder, sour agent and Just the right amount of fragrance.
在以上范围内,粉状品实施例为:硫酸钡60%、麸皮细粉30%、阿拉伯胶粉1%、糖粉8.2%、0.8%柠檬酸、香精适量。使用时根据个人口味等水调浓度50~80%(w/w或w/v),一次口服其100~250g。如系钡灌肠,糖粉及柠檬酸等调味品可取消或酌减,前二者可酌加,根据当时情况遵医嘱使用量150~300g。Within the above range, the powdery product embodiment is: 60% of barium sulfate, 30% of bran powder, 1% of gum arabic powder, 8.2% of powdered sugar, 0.8% citric acid, and an appropriate amount of essence. When in use, adjust the concentration by 50-80% (w/w or w/v) according to personal taste and other water, and take 100-250 g of it orally once. In the case of barium enema, condiments such as sugar powder and citric acid can be canceled or reduced, and the former two can be added at discretion. According to the situation at that time, the dosage is 150-300g according to the doctor's advice.
实施例2.粉状品:在使用时医护人员根据情况和要求用水来调和。Embodiment 2. Powdered product: when in use, the medical staff will mix it with water according to the situation and requirements.
硫酸钡20~70%、麸皮(或谷糠等,经去除蛋白质和淀粉的处理或否)细粉20~70%、阿拉伯胶粉0.5~1%、山楂果粉5~9%、甜味剂、酸味剂及香精适量。Barium sulfate 20-70%, bran (or rice bran, etc., treated to remove protein and starch or not) fine powder 20-70%, gum arabic powder 0.5-1%, hawthorn fruit powder 5-9%, sweetener , sour agent and flavor amount.
在以上范围内,此种粉状品实施例为:硫酸钡60%、麸皮细粉30%、阿拉伯胶粉1%、山楂果粉9%、甜蜜素及香精适量。使用时根据个人口味水调浓度50~80%(w/w或w/v),遵医嘱一次口服其100~250g。如系钡灌肠,前二者酌加(余可取消),据情使用量为150~300g。Within the above range, the embodiment of this powder product is: 60% of barium sulfate, 30% of fine bran powder, 1% of gum arabic powder, 9% of hawthorn fruit powder, appropriate amount of cyclamate and essence. When in use, adjust the concentration of water to 50-80% (w/w or w/v) according to personal taste, and take 100-250g of it once orally as directed by the doctor. In the case of barium enema, add the first two at discretion (the rest can be canceled), and the dosage is 150-300g according to the situation.
实施例3.粉状品:在使用时医护人员根据情况和要求用水来调和。Embodiment 3. Powdered product: when in use, the medical staff will mix it with water according to the situation and requirements.
硫酸钡20~70%、甘薯粉细粉20~70%、甜味剂、酸味剂及香精适量。20-70% of barium sulfate, 20-70% of sweet potato powder, appropriate amount of sweetener, sour agent and essence.
在以上范围内,此种粉状品实施例为:硫酸钡64%、甘薯细粉36%、甜蜜素及香精适量。使用时根据个人口味水调浓度50~80%(w/w或w/v),遵医嘱一次口服其100~250g。如系钡灌肠,前二者酌加(余可取消),使用量150~300g。Within the above range, the embodiment of this powder product is: barium sulfate 64%, sweet potato powder 36%, appropriate amount of cyclamate and essence. When in use, adjust the concentration of water to 50-80% (w/w or w/v) according to personal taste, and take 100-250g of it once orally as directed by the doctor. If it is barium enema, add the first two at discretion (the rest can be canceled), and the dosage is 150-300g.
实施例4.酱膏状品:直接使用(或食用),或适当加水稀释使用。Embodiment 4. Sauce paste product: directly use (or eat), or suitably add water to dilute and use.
硫酸钡20~60%、麸皮(或谷糠等,经去除蛋白质和淀粉的处理或否)细粉20~50%、阿拉伯胶粉0.5~1.5%、果浆10~15%、水10~15%、糖粉8~9%、酸味剂、防腐剂及香精适量。Barium sulfate 20-60%, bran (or rice bran, etc., after removing protein and starch or not) fine powder 20-50%, Arabic gum powder 0.5-1.5%, fruit pulp 10-15%, water 10- 15%, powdered sugar 8-9%, sour agent, preservative and essence in right amount.
在以上范围内,酱膏状品实施例为:硫酸钡50%、麸皮细粉25%、阿拉伯胶粉1%、果浆10%、水5%、糖粉8%、0.8%柠檬酸、山梨酸钾0.1%、香精适量(w/w或w/v)。使用时再加入适量水调,直至适于口服。遵医嘱一般一次口服量120~300g。Within the above range, the paste-like product embodiment is: barium sulfate 50%, fine bran powder 25%, gum arabic powder 1%, fruit pulp 10%, water 5%, powdered sugar 8%, 0.8% citric acid, Potassium sorbate 0.1%, appropriate amount of essence (w/w or w/v). When in use, add appropriate amount of water until it is suitable for oral administration. According to the doctor's advice, the general oral dose is 120-300g at a time.
实施例5.酱膏状品:直接使用(或食用),或适当加水稀释使用。Embodiment 5. Sauce paste product: directly use (or eat), or use after being diluted with water appropriately.
硫酸钡20~60%、甘薯细粉20~50%、阿拉伯胶粉0.5~1.5%、果浆10~15%、水10~15%、糖粉8~9%、酸味剂、防腐剂及香精适量。Barium sulfate 20-60%, sweet potato powder 20-50%, Arabic gum powder 0.5-1.5%, fruit pulp 10-15%, water 10-15%, sugar powder 8-9%, sour agent, preservative and essence Appropriate amount.
在以上范围内,此种酱膏状品实施例为:硫酸钡50%、甘薯细粉25%、阿拉伯胶粉1%、果浆10%、水5%、糖粉8%、0.8%柠檬酸、山梨酸钾0.1%、香精适量(w/w或w/v)。使用时再加入适量水调,直至适于口服。遵医嘱一般一次口服量120~300g。Within the above range, the embodiment of this kind of paste product is: barium sulfate 50%, sweet potato fine powder 25%, gum arabic powder 1%, fruit pulp 10%, water 5%, sugar powder 8%, 0.8% citric acid , potassium sorbate 0.1%, appropriate amount of flavor (w/w or w/v). When in use, add appropriate amount of water until it is suitable for oral administration. According to the doctor's advice, the general oral dose is 120-300g at a time.
实施例6.糊浆状品:其含水量最高,基本可供使用时直接食用,由于放置时可能会发生沉降,使用时可尽量摇匀。Embodiment 6. Paste-like product: its water content is the highest, and it can be eaten directly when it is basically available for use. Since sedimentation may occur when placed, it can be shaken as much as possible when used.
硫酸钡20~60%、麸皮(或谷糠等,经去除蛋白质和淀粉的处理或否)细粉20~30%、阿拉伯胶粉0.5~1.5%、果浆10~15%、水20~35%、糖粉8~9%、酸味剂、防腐剂及香精适量。Barium sulfate 20-60%, bran (or rice bran, etc., treated to remove protein and starch or not) fine powder 20-30%, gum arabic powder 0.5-1.5%, fruit pulp 10-15%, water 20- 35%, powdered sugar 8-9%, sour agent, preservative and essence in right amount.
在以上范围内,糊浆状品实施例为:硫酸钡40%、麸皮细粉20%、阿拉伯胶粉1%、果浆10%、糖粉8%、0.8%柠檬酸、山梨酸钾0.05%、水20%、香精适量(w/w或w/v)。遵医嘱一般一次口服其120~500g。Within the above range, the embodiment of the paste product is: barium sulfate 40%, bran fine powder 20%, gum arabic powder 1%, fruit pulp 10%, sugar powder 8%, 0.8% citric acid, potassium sorbate 0.05 %, 20% water, appropriate amount of essence (w/w or w/v). According to the doctor's advice, generally take 120-500g orally once.
实施例7.糊浆状品:Embodiment 7. paste product:
硫酸钡20~60%、甘薯细粉20~30%、阿拉伯胶粉0.5~1.5%、果浆10~15%、水20~35%、糖粉8~9%、酸味剂、防腐剂及香精适量。Barium sulfate 20-60%, sweet potato powder 20-30%, Arabic gum powder 0.5-1.5%, fruit pulp 10-15%, water 20-35%, sugar powder 8-9%, sour agent, preservative and essence Appropriate amount.
在以上范围内,糊浆状品实施例为:硫酸钡40%、甘薯细粉20%、阿拉伯胶粉1%、果浆10%、糖粉8%、0.8%柠檬酸、山梨酸钾0.05%、水20%、香精适量(w/w或w/v)。遵医嘱一般一次口服120~500g。Within the above range, the embodiment of paste product is: 40% barium sulfate, 20% sweet potato powder, 1% gum arabic powder, 10% pulp, 8% sugar powder, 0.8% citric acid, 0.05% potassium sorbate , 20% water, appropriate amount of essence (w/w or w/v). According to the doctor's advice, generally take 120-500g orally once.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03112182 CN1202866C (en) | 2003-04-23 | 2003-04-23 | Gastrointestinal contrast agent containing biomass |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03112182 CN1202866C (en) | 2003-04-23 | 2003-04-23 | Gastrointestinal contrast agent containing biomass |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1444997A CN1444997A (en) | 2003-10-01 |
CN1202866C true CN1202866C (en) | 2005-05-25 |
Family
ID=27814615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03112182 Expired - Fee Related CN1202866C (en) | 2003-04-23 | 2003-04-23 | Gastrointestinal contrast agent containing biomass |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1202866C (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100356983C (en) * | 2005-11-18 | 2007-12-26 | 山东大学 | Biotechnological treating method of biomass for stomach intestine contrast-media |
CN101496905B (en) * | 2009-02-27 | 2010-09-15 | 莱芜钢铁集团有限公司医院 | Marker for function check of stomach and intestine and preparation method thereof |
CN103948945B (en) * | 2014-05-04 | 2016-04-27 | 青岛市中心医院 | A kind of capsule barium meal and preparation method thereof |
US9989482B2 (en) * | 2016-02-16 | 2018-06-05 | General Electric Company | Methods for radiographic and CT inspection of additively manufactured workpieces |
CN109540936A (en) * | 2019-01-11 | 2019-03-29 | 大连大学附属中山医院 | It is a kind of for high-resolution ct and the room temperature contrast agent of x-ray artery, vein or pipeline and preparation method thereof |
CN110031278A (en) * | 2019-05-10 | 2019-07-19 | 于大志 | A kind of angiography liquid, injection device and its application |
-
2003
- 2003-04-23 CN CN 03112182 patent/CN1202866C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1444997A (en) | 2003-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103719221B (en) | Crisp wheat-bran cookie rich in multiple coarse cereals and making method of crisp wheat-bran cookie with multiple coarse cereals | |
WO2016019597A1 (en) | Comprehensive nutrition powder and preparation method therefor | |
CN107467462A (en) | A kind of generation meal solid beverage for contributing to fat-reducing and preparation method thereof | |
CN106261439A (en) | Protein Diets fiber meal replacement powder and preparation method | |
CN101057643A (en) | Rice with blood sugar reducing function | |
CN115918889A (en) | Composite gel for weight control and preparation method and application thereof | |
CN1202866C (en) | Gastrointestinal contrast agent containing biomass | |
CN104585637A (en) | Prepared porridge with purple sweet potatoes and oat and preparation method of prepared porridge | |
CN108308480A (en) | A kind of biology weight reducing drop is high to dredge secret health products and preparation method thereof | |
CN115590069A (en) | Composition containing pea peptide and preparation method and application thereof | |
CN1225191C (en) | Method for preparing flaxseed foods using flaxseed as raw material | |
CN1973665A (en) | Cured fruit-vegetable sauce without cane sugar and its prepn process | |
JP2016034239A (en) | Health food | |
CN1166322C (en) | A kind of method that uses linseed as raw material to prepare beverage | |
CN102919676A (en) | Hulless oat bran nutrition powder for losing weight and preparation method thereof | |
CN105101817B (en) | Edible composition and preparation method thereof and the food comprising said composition | |
CN117837664A (en) | A kind of alcohol-relieving and liver-protecting compressed candy and preparation method thereof | |
CN1929752A (en) | Process for producing health food containing dietary fiber | |
CN105533627B (en) | A kind of method that bamboo shoot process residue prepares solid-state ferment flavouring | |
CN104305229B (en) | A kind of stem of noble dendrobium dietary fiber food and its processing method | |
CN109893641B (en) | Direct-access oral ginger powder with functions of clearing and moistening throat and preparation method thereof | |
JPH09278664A (en) | New dietary fiber composition | |
JP2011152105A (en) | Food product for promoting alkylphenol-based compound excretion | |
CN1067865C (en) | Carrot snack porridge and prodn. method | |
CN1119076A (en) | Formula of Ilex kudingcha series health food and producing process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050525 Termination date: 20100423 |